The administration of the Drp-1 inhibitor in a model of global ischemic brain with IPC impaired brain mitophagy, resulting in increased neuronal damage in the CA3 hippocampus after cerebral ischemia [12]. The gene discussed is DNM1L; the disease is Cerebral ischemia.